Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (121-130 of 431) with videos related to

Pageof 44
Sort By:
Calcified Tissue International|April 13, 2025
Long-Term Denosumab Treatment in Adults with Juvenile Paget DiseaseStergios A Polyzos, Konstantinos Anastasilakis, Tim Cundy, et al.
Journal of Gastrointestinal Cancer|December 5, 2022
Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer PathophysiologyJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Journal of Clinical Gastroenterology|August 19, 2010
The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literatureStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Helicobacter|March 26, 2011
The association between Helicobacter pylori infection and insulin resistance: a systematic reviewStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Hormones (Athens, Greece)|September 8, 2019
Selenium and selenoprotein P in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Antonis Goulas, et al.
Minerva Endocrinologica|February 10, 2017
Thyroid dysfunction and non-alcoholic fatty liver diseaseZoe A Efstathiadou, Marina D Kita, Stergios A Polyzos
Annals of Gastroenterology|May 9, 2020
National consensus on <i>Helicobacter pylori</i> infection: the next-day challengeApostolis Papaefthymiou, Michael Doulberis, Stergios A Polyzos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2020
Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation riskJannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Spironolactone revisitedStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Journal of Clinical Gastroenterology|March 8, 2012
Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit diseaseStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Pageof 44

Showing results (121-130 of 431) with videos related to

Sort By:
Pageof 44
Calcified Tissue International|April 13, 2025
Long-Term Denosumab Treatment in Adults with Juvenile Paget DiseaseStergios A Polyzos, Konstantinos Anastasilakis, Tim Cundy, et al.
Journal of Gastrointestinal Cancer|December 5, 2022
Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer PathophysiologyJannis Kountouras, Apostolis Papaefthymiou, Stergios A Polyzos, et al.
Journal of Clinical Gastroenterology|August 19, 2010
The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literatureStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Helicobacter|March 26, 2011
The association between Helicobacter pylori infection and insulin resistance: a systematic reviewStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Hormones (Athens, Greece)|September 8, 2019
Selenium and selenoprotein P in nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Antonis Goulas, et al.
Minerva Endocrinologica|February 10, 2017
Thyroid dysfunction and non-alcoholic fatty liver diseaseZoe A Efstathiadou, Marina D Kita, Stergios A Polyzos
Annals of Gastroenterology|May 9, 2020
National consensus on <i>Helicobacter pylori</i> infection: the next-day challengeApostolis Papaefthymiou, Michael Doulberis, Stergios A Polyzos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2020
Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation riskJannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Spironolactone revisitedStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Journal of Clinical Gastroenterology|March 8, 2012
Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit diseaseStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Pageof 44